How Investors Are Reacting To Indivior (INDV) Real-World SUBLOCADE Data On Remission-Focused OUD Treatment [Yahoo! Finance]
Indivior PLC (INDV)
Company Research
Source: Yahoo! Finance
monthly extended-release buprenorphine injection SUBLOCADE supports remission and reduces overdose risk in opioid use disorder treatment. The findings emphasize that sustained, evidence-based medication treatment can support lasting recovery outcomes beyond simple abstinence, potentially influencing how clinicians, payers, and policymakers define successful opioid use disorder care. We'll now examine how this new real-world evidence for SUBLOCADE as a remission-focused therapy could shape Indivior's broader investment narrative. Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution. Indivior Pharmaceuticals Investment Narrative Recap To own Indivior, you have to believe that long acting injectables can become a core standard of care in opioid use disorder and that SUBLOCADE remains a leader in that category. The new real world data underscoring remission and overdose risk reduction strengthens the
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC news events
Weekly update
A roundup of the hottest topics
INDV
News
- Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder [Yahoo! Finance]Yahoo! Finance
- Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use DisorderGlobeNewswire
- Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse [Yahoo! Finance]Yahoo! Finance
- Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication MisuseGlobeNewswire
- Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th GlobeNewswire
INDV
Earnings
- 2/26/26 - Beat
INDV
Sec Filings
- 4/28/26 - Form SCHEDULE
- 4/27/26 - Form SCHEDULE
- 3/27/26 - Form ARS
- INDV's page on the SEC website